David Marcilla
Overview
Explore the profile of David Marcilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuadras M, Semidey M, Planas J, de Torres I, Regis L, Celma A, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769252
Pelvic lymph node dissection (PLND) is the most accurate procedure for lymph node (LN) staging in prostate cancer (PCa) patients. LN sectioning and hematoxylin and eosin (H&E) staining of at...
2.
Salguero-Aranda C, Perez M, Vargas-Padilla M, Beltran-Povea A, Delgado-Bellido D, Marcilla D, et al.
Arch Pathol Lab Med
. 2024 Oct;
PMID: 39384185
Context.—: Sarcomas are rare and highly heterogeneous mesenchymal tumors with deceptive morphologic features that pose a challenge for precise diagnostics. Chromosomal rearrangements generating pathognomonic gene fusions are useful diagnostic markers,...
3.
Carrillo-Garcia J, Hindi N, Conceicao M, Sala M, Ugalde A, Lopez-Pousa A, et al.
Eur J Cancer
. 2024 Aug;
209:114270.
PMID: 39142211
Purpose: Prognostic biomarkers remain necessary in sporadic desmoid tumor (DT) because the clinical course is unpredictable. DT location along with gene expression between thoracic and abdominal wall locations was analyzed....
4.
Moura D, Mondaza-Hernandez J, Sanchez-Bustos P, Pena-Chilet M, Cordero-Varela J, Lopez-Alvarez M, et al.
Cell Mol Life Sci
. 2024 May;
81(1):219.
PMID: 38758230
HMGA1 is a structural epigenetic chromatin factor that has been associated with tumor progression and drug resistance. Here, we reported the prognostic/predictive value of HMGA1 for trabectedin in advanced soft-tissue...
5.
Salguero-Aranda C, Di Blasi E, Galan L, Zaldumbide L, Civantos G, Marcilla D, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38339014
Recurrent gene fusions (GFs) in translocated sarcomas are recognized as major oncogenic drivers of the disease, as well as diagnostic markers whose identification is necessary for differential diagnosis. is a...
6.
Martin-Broto J, Martinez-Garcia J, Moura D, Redondo A, Gutierrez A, Lopez-Pousa A, et al.
Signal Transduct Target Ther
. 2023 Oct;
8(1):405.
PMID: 37875500
Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors demonstrated activity in terms of progression-free survival (PFS) in advanced dedifferentiated liposarcoma (DD-LPS), a sarcoma with CDK4 amplification. CDK4 overexpression is by far...
7.
Martin-Broto J, Redondo A, Moura D, Valverde C, Morales J, Lopez-Pousa A, et al.
Nat Commun
. 2022 Oct;
13(1):6278.
PMID: 36271011
Desmoid fibromatosis (DF) are mesenchymal neoplasms, with potential aggressive course and relevant clinical impact. New systemic therapy modalities are needed in this symptomatic/progressive population. In this multicenter, phase II trial...
8.
Salguero-Aranda C, Martinez-Reguera P, Marcilla D, de Alava E, Diaz-Martin J
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680383
Risk stratification of solitary fibrous tumor (SFT) patients based on clinicopathological features has limited efficacy, especially in predicting late relapse or metastasis. The hallmark alteration of SFT is the gene...
9.
Hindi N, Carrasco Garcia I, Sanchez-Camacho A, Gutierrez A, Peinado J, Rincon I, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33805586
The authors noticed that content of "Conflicts of Interest" in the original version [...].
10.
Marcilla D, Machado I, Grunewald T, Llombart-Bosch A, de Alava E
Methods Mol Biol
. 2020 Dec;
2226:49-64.
PMID: 33326093
The diagnosis of Ewing sarcoma requires the integration of the information generated from numerous techniques, some of them being very sophisticated. However, the first steps of the diagnostic process are...